give the dog a bone
18 Jan 2018
Re: New CEO ... hmm! that kitchen sink doesn't look too good. possibly a case of 'best to start the provisioning ' that those expensive consultants talked abou
Hardboy
18 Jan 2018
New CEO Is announced and the sp drops. Not very welcoming to the new boss is it?
EssentialInvestor
04 Nov 2017
Results look strong The growth continues, very pleased with results and outlook.
EssentialInvestor
29 Sep 2017
Nascent growth story In the specialist food ingredients division.The fluctuations in bulk ingredients may mask the overall business potential IMV.Please DYOR as always.
EssentialInvestor
13 Sep 2017
Tasty Tate?. Growth rates in the speciality business, particularly in some emerging markets,are notable.There is some uncertainty with the future of NAFTA, commodity volatility also a consideration.Under it all looks an interesting cash generative business. Just my take only.
DrRadcliffe
04 Jun 2017
Re: Drop I thought the results good too and couldn't see anything to worry except that perhaps future share price growth will come about through Sterling weakness more than anything else. Obviously the business is running efficiently on all cylinders. I bought £10000 worth last week as a hedge against a poor result for the Tories. Only a small part of Tate's revenues come from the UK.
Bryan67
03 Jun 2017
Re: Drop Thinking the same. No-one seems that informed on this Board though.
Hydrogen Economy
26 May 2017
Drop I am surprised at the market reaction to what seemed very positive results, did anyone spot any issue hidden between the positives?I've been waiting for an opportunity to enter and this looks like it might be - but a little wary of sustained fall.H2
Warren Buffoon
25 May 2017
Dividend cover Glad dividend cover is up, would have liked a little uplift in the divi itself. . . . .
II Editor
10 Feb 2017
NEW ARTICLE: Stockwatch: Turnaround with 23% upside "Is LSE:TATE:Tate & Lyle's turnaround intact? Weak commodity prices and supply chain issues triggered a fall in Tate & Lyle shares from 883p in 2013 to 502p in the summer of 2015. Then came a strong recovery to 810p, only for the shares to plunge ..."[link]
cta100
16 Jan 2017
Re: Share Buy Back & Prospects It is the FX impact that concerns me at the moment, not as straight forward as weak sterling equals better earnings due to overseas bias. The Mexican Peso in particular, which a lot of the sales to the US drinks manufacturers are in, is at an all time low. The visibility of this effect in the accounts is poor - except for the company stating that hedges to some degree and MXN is 2nd most important currency after USD.I would also view NAFTA break up as a risk, as could slap on a tariff on those exports into the US. This won't happen overnight when Trump comes in, but he has already put some direct pressure on US car manufactures looking to build their new plants south of the border and had go at BMW recently to the same effect. Some of the value metrics are attractive but not without political risk. The FT did a couple of good articles on the above during ~Q3 last year which could google if want further info.
numberbiter
16 Jan 2017
Re: Share Buy Back LK, i think you are right. All of Tate&Lyle's products have very low margins. They will likely survive, but the prospects of reasonable growth are slim.
LK Hyman
16 Jan 2017
Re: Share Buy Back & Prospects H2,All sensible comments of yours, m8. I used to hold TATE for several years and my image of it is as a serial disappointer over the long haul. Things may be different now but I'm disinclined to take a long position in it mesen. Good luck if you feel otherwise; you could well be right.LKH on the flybridge
Hydrogen Economy
16 Jan 2017
Share Buy Back & Prospects Buy-back is purely administrative, RNS on 13th. indicated "The Company intends to hold these shares in Treasury to satisfy awards made under employee performance share plans."I have been considering a purchase here. The valuation depends a lot on the growth TATE can achieve in their new products. They have built this business from scratch to sales of 86m since 2012. The indicated target sales of 200m by 2020 looks a stretch but they seem confident, there appears to be good progress in the speciality products division.I think they have made a smart move in shifting out of sugar and focusing on other products, particularly those in the health food area which looks set to continue to grow. T&L are leading suppliers into the energy bar and yoghurt drink markets and splenda is a leading brand in the huge low-cal drinks market. Fx will support earnings which are nearly all overseas, but significant debt in USD/Eur likely to balance that somewhat.Forecast EPS from Digital Look (normally adjusted) for 2017-19 is 44.8 47.77 49.04 traders normally quote unadjusted numbers - 41.3 43.6 46Either way well up on 2016 EPS of 34.5p, 34.7p or 34.8p depending whether you take it diluted, adjusted or straight.Div is forecast to rise modestly from 28p in 16 to 29.5p in 2019, a solid 4%+ at current SP with decent potential for capital gain.Clearly there is some execution risk, food markets, especially health foods can be fickle, but on balance I am inclined to take a modest position here, maybe upto 3%.Appreciate any thoughts or comments.H2
The White Rider
13 Jan 2017
Re: Share Buy Back Seems like a drop in the ocean - up to 2M against 466M issued shares. Hate to be pessimistic but effect on dividend seems minimal. Or am I missing the point.As always, DYO
